Evommune, Inc.

EVMNNYSE· Pharmaceutical Preparations

Price History

Revenue

$13.0M

▲ 85.7% YoY

Net Income

-$68.9M

▼ 3.1% YoY

EPS

$-11.22

▲ 75.2% YoY

Cash

$44.1M

▲ 171.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.